Cargando…
Feasibility of Using NF1-GRD and AAV for Gene Replacement Therapy in NF1-Associated Tumors
Neurofibromatosis type 1, including the highly aggressive malignant peripheral nerve sheath tumors (MPNSTs), is featured by the loss of functional neurofibromin 1 (NF1) protein resulting from genetic alterations. A major function of NF1 is suppressing Ras activities, which is conveyed by an intrinsi...
Autores principales: | Bai, Ren-Yuan, Esposito, Dominic, Tam, Ada J., McCormick, Frank, Riggins, Gregory J., Clapp, D. Wade, Staedtke, Verena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588423/ https://www.ncbi.nlm.nih.gov/pubmed/31127187 http://dx.doi.org/10.1038/s41434-019-0080-9 |
Ejemplares similares
-
An Operational Tool for the Automatic Detection and Removal of Border Noise in Sentinel-1 GRD Products
por: Stasolla, Mattia, et al.
Publicado: (2018) -
Preventative Effect of Mebendazole against Malignancies in Neurofibromatosis 1
por: Staedtke, Verena, et al.
Publicado: (2020) -
Prevention of tumor seeding during needle biopsy by chemotherapeutic-releasing gelatin sticks
por: Bai, Ren-Yuan, et al.
Publicado: (2017) -
Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model
por: Williamson, Tara, et al.
Publicado: (2016) -
Brainstem ischemic syndrome in juvenile NF2
por: Henson, John W., et al.
Publicado: (2020)